ЖурналыПодпискаАрхивКнигиПроектыО насРекламаДоставка/ОплатаКонтакты
+7 (495) 482-43-29
  • Главная
  • / Журналы
  • / Вернуться в журнал
  • / Содержание номера
  • / Статья
IDH-мутантные глиомы. Текущее состояние проблемы

IDH-мутантные глиомы. Текущее состояние проблемы

Авторы:
Марина Владимировна Рыжова

Журнал: Вопросы нейрохирургии имени Н.Н. Бурденко. 2026;90(5):70-75.

DOI: 10.17116/neiro20269005170

Прочитано: 114 раз

Резюме

В статье рассматривается текущая ситуация в РФ с современной диагностикой IDH-мутантных глиом: возможности предсказательной нейровизуализационной диагностики, интраоперационной масс-спектрометрии, традиционного иммуногистохимического и молекулярного анализа парафиновых блоков и выглядящей многообещающей таргетной терапии препаратами — ингибиторами IDH.

Ключевые слова

  • IDH
  • глиомы
  • таргетные ингибиторы

Конфликт интересов

Автор заявляет об отсутствии конфликта интересов.

Дата поступления: 20.05.2026

Дата принятия в печать: 20.07.2026

Дата публикации: 16.10.2026

Литература / References
  1. Wesseling P, Capper D, Reifenberger G, Sarkar C, Hawkins C, Perry A, Kleinschmidt-DeMasters B, Komori T, Paulus W, Santosh V, van den Bent M, Weller M, Pfister SM, Tabori U, Figarella-Branger D, Orr BA, Louis DN. cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumors. Brain Pathology. 2026;36(1):e70035. https://doi.org/10.1111/bpa.70035
  2. WHO Classification of Tumours Editorial Board. Central nervous system tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2021. (WHO Classification of Tumours; vol. 6).
  3. Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blümcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schüller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469-474. https://doi.org/10.1038/nature26000
  4. Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, Schweizer L, Banan R, Reuss D, Suwala A, Korshunov A, Stichel D, Wefers AK, Hau AC, Boldt H, Harter PN, Abdullaev Z, Benhamida J, Teichmann D, Koch A, Hench J, Frank S, Hasselblatt M, Mansouri S, Díaz de Ståhl T, Serrano J, Ecker J, Selt F, Taylor M, Ramaswamy V, Cavalli F, Berghoff AS, Bison B, Blattner-Johnson M, Buchhalter I, Buslei R, Calaminus G, Dikow N, Dohmen H, Euskirchen P, Fleischhack G, Gajjar A, Gerber NU, Gessi M, Gielen GH, Gnekow A, Gottardo NG, Haberler C, Hamelmann S, Hans V, Hansford JR, Hartmann C, Heppner FL, Driever PH, von Hoff K, Thomale UW, Tippelt S, Frühwald MC, Kramm CM, Schüller U, Schittenhelm J, Schuhmann MU, Stein M, Ketteler P, Ladanyi M, Jabado N, Jones BC, Jones C, Karajannis MA, Ketter R, Kohlhof P, Kordes U, Reinhardt A, Kölsche C, Lamszus K, Lichter P, Maas SLN, Mawrin C, Milde T, Mittelbronn M, Monoranu CM, Mueller W, Mynarek M, Northcott PA, Pajtler KW, Paulus W, Perry A, Blümcke I, Plate KH, Platten M, Preusser M, Pietsch T, Prinz M, Reifenberger G, Kristensen BW, Kool M, Hovestadt V, Ellison DW, Jacques TS, Varlet P, Etminan N, Acker T, Weller M, White CL, Witt O, Herold-Mende C, Debus J, Krieg S, Wick W, Snuderl M, Aldape K, Brandner S, Hawkins C, Horbinski C, Thomas C, Wesseling P, von Deimling A, Capper D, Pfister SM, Jones DTW, Sahm F. Advancing CNS tumor diagnostics with expanded DNA methylation-based classification. Cancer Cell. 2026;44(2):340-354.e2. https://doi.org/10.1016/j.ccell.2025.11.002
  5. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Первичные опухоли центральной нервной системы. 2025
  6. Sahm F, Aldape KD, Brastianos PK, Brat DJ, Dahiya S, von Deimling A, Giannini C, Gilbert MR, Louis DN, Raleigh DR, Reifenberger G, Santagata S, Sarkar C, Zadeh G, Wesseling P, Perry A. cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Neuro-Oncology. 2025;27(2):319-330. https://doi.org/10.1093/neuonc/noae170
  7. Aldape K, Capper D, von Deimling A, Giannini C, Gilbert MR, Hawkins C, Hench J, Jacques TS, Jones D, Louis DN, Mueller S, Orr BA, Nasrallah M, Pfister SM, Sahm F, Snuderl M, Solomon D, Varlet P, Wesseling P. cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics. Neuro-Oncology Advances. 2025;7(1):vdae228. https://doi.org/10.1093/noajnl/vdae228
  8. Hawkins C, Aldape K, Capper D, von Deimling A, Giannini C, Gilbert MR, Jacques TS, Jones D, Komori T, Louis DN, Mueller S, Nasrallah M, Orr BA, Perry A, Pfister SM, Sahm F, Sarkar C, Snuderl M, Solomon D, Varlet P, Wesseling P, Reifenberger G. cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification. Brain Pathology. 2025;35(6):e70018. https://doi.org/10.1111/bpa.70018
  9. Park JW, Kwak J, Kim KW, Jung S, Nam CH, Kim HJ, Lee SM, Choi C, Ahn Y, Park JH, Yoo J, Shim JK, Cho HJ, Kim EH, Kim C, Ahn S, Pusch S, von Deimling A, Chang JH, Kim SH, Kim H, Ju YS, Kang SG, Lee JH. IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation. Science. 2026;391(6781):eadt0559. https://doi.org/10.1126/science.adt0559
  10. Mount CW, Suvà ML. The source of IDH-mutant gliomas. Science. 2026; 391(6781):125-126. https://doi.org/10.1126/science.aed6843
  11. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807-1812. https://doi.org/10.1126/science.1164382
  12. Cui M, Zhang M, Zhou C, Sun G, Zhang J. Multimodal techniques for maximal safe resection of IDH-mutant low-grade glioma involving corpus callosum, a retrospective study and prognosis analysis. Chinese Neurosurgical Journal. 2026;12(1):13. https://doi.org/10.1186/s41016-026-00432-y
  13. Goldbrunner R, Foroglou N, Signorelli F, Schucht P, Jakola AS, Minniti G, Rola R, Renovanz M, Preusser M, Furtner J, Grossman R, Mawrin C, Demetriades A, Weller M, Simon M. EANS-EANO guidelines on the extent of resection in gliomas. Neuro-Oncology. 2026;28(1):38-54. https://doi.org/10.1093/neuonc/noaf217
  14. Mayerhoefer ME, Materka A, Langs G, Häggström I, Szczypiński P, Gibbs P, Cook G. Introduction to Radiomics. Journal of Nuclear Medicine. 2020;61(4):488-495. https://doi.org/10.2967/jnumed.118.222893
  15. Zhang X, Lai Q, Cao J, Ching JCF, Teng X, Zhang J, Lee SWY, Ren G, Cai J. Radiogenomics: Current Understandings and Future Perspectives. Medicine Communications. 2026;7(2):e70583. https://doi.org/10.1002/mco2.70583
  16. Ohizumi Y, Kurokawa R, Watanabe Y, Kurokawa M, Kitagawa Y, Nomura M, Takami H, Saito N, Abe O. Conventional MRI/CT for differentiation of IDH-mutant adult-type diffuse gliomas: revisited with a new imaging feature “scFLAIR-D”. Japanese Journal of Radiology. 2026;44(7):1142-1149. https://doi.org/10.1007/s11604-026-01965-z
  17. Ying Y, Yu Q, Ren Y, Zhao Y, Wang D, Mei N, Ruan Z, Xie Y, Chen J, Cui J, Pan J, Lu K, Qin Z, Lu Y, Yin B. 5T-Based Glutamate Chemical Exchange Saturation Transfer Imaging for Adult Diffuse Glioma Stratification. Journal of Magnetic Resonance Imaging. 2026;64(2):415-426. https://doi.org/10.1002/jmri.70340
  18. Branzoli F, Liserre R, Deelchand DK, Poliani PL, Bielle F, Nichelli L, Sanson M, Lehéricy S, Marjańska M. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by In Vivo MR Spectroscopy. Radiology. 2023;308(3):e223255. https://doi.org/10.1148/radiol.223255
  19. He L, Zhang H, Li T, Yang J, Zhou Y, Wang J, Saidaer T, Bai X, Liu X, Wang Y, Wang L. Identifying IDH-mutant and 1p/19q noncodeleted astrocytomas from nonenhancing gliomas: Manual recognition followed by artificial intelligence recognition. Neuro-Oncology Advances. 2024;6(1):vdae013. https://doi.org/10.1093/noajnl/vdae013
  20. Onishi S, Yamasaki F, Akiyama Y, Kawahara D, Amatya VJ, Yonezawa U, Taguchi A, Ozono I, Khairunnisa NI, Takeshima Y, Horie N. Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign. Journal of Neuro-Oncology. 2024;170(2):429-436. https://doi.org/10.1007/s11060-024-04794-0
  21. Hua W, Zhang W, Brown H, Wu J, Fang X, Shahi M, Chen R, Zhang H, Jiao B, Wang N, Xu H, Fu M, Wang X, Zhang J, Zhang X, Wang Q, Zhu W, Ye D, Garcia DM, Chaichana K, Cooks RG, Ouyang Z, Mao Y, Quinones-Hinojosa A. Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry. Proceedings of the National Academy of Sciences of the United States of America. 2024;121(23):e2318843121. https://doi.org/10.1073/pnas.2318843121
  22. Shahi M, Pringle S, Morris M, Garcia DM, Quiñones-Hinojosa A, Cooks RG. Detection of IDH mutation in glioma by desorption electrospray ionization (DESI) tandem mass spectrometry. Scientific Reports. 2024; 14(1):26865. https://doi.org/10.1038/s41598-024-77044-y
  23. Haapala I, Kondratev A, Roine A, Mäkelä M, Kontunen A, Karjalainen M, Laakso A, Koroknay-Pál P, Nordfors K, Haapasalo H, Oksala N, Vehkaoja A, Haapasalo J. Method for the Intraoperative Detection of IDH Mutation in Gliomas with Differential Mobility Spectrometry. Current Oncology. 2022; 29(5):3252-3258. https://doi.org/10.3390/curroncol29050265
  24. Longuespée R, Wefers AK, De Vita E, Miller AK, Reuss DE, Wick W, Herold-Mende C, Kriegsmann M, Schirmacher P, von Deimling A, Pusch S. Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry. Acta Neuropathologica Communications. 2018;6(1):21. https://doi.org/10.1186/s40478-018-0523-3
  25. Рыжова М.В., Галстян С.А., Телышева Е.Н., Пицхелаури Д.И., Косырькова А.В., Латышев Я.А. IDH-мутантная глиома ствола. Вопросы нейрохирургии им. Н.Н. Бурденко. 2022;86(6):52-57 https://doi.org/10.17116/neiro20228606152
  26. Chang EK, Smith-Cohn MA, Tamrazi B, Ji J, Krieger M, Holdhoff M, Eberhart CG, Margol AS, Cotter JA. IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature. Brain Pathology. 2021;31(4):e12959. https://doi.org/10.1111/bpa.12959
  27. Husain A, Mishra S, Siddiqui MH, Husain N. Detection of IDH1 Mutation in cfDNA and Tissue of Adult Diffuse Glioma with Allele-Specific qPCR. Asian Pacific Journal of Cancer Prevention. 2023;24(3):961-968. https://doi.org/10.31557/APJCP.2023.24.3.961
  28. Nelson EJ, Gubbiotti MA, Carlin AM, Nasrallah MP, Van Deerlin VM, Herlihy SE. Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas. Molecular Diagnosis & Therapy. 2023;27(3):371-381. https://doi.org/10.1007/s40291-022-00638-7
  29. FDA approves first IDH-targeted glioma drug. Nature Biotechnology. 2024; 42(9):1325. https://doi.org/10.1038/s41587-024-02408-8
  30. Bridgewater J, Tabatabai G, Macarulla T, Stacchiotti S. Clinical advancement in the management of mutant isocitrate dehydrogenase (IDH) cancers. European Journal of Cancer Supplements. 2026;17:11-19. https://doi.org/10.1016/j.ejcsup.2025.12.001
  31. Rudà R, Bruno F, Pellerino A, Pronello E, Soffietti R. Low-grade IDH-mutant gliomas: from standard post-surgical treatments to novel IDH inhibitors. Expert Opinion on Pharmacotherapy. 2025;26(10):1163-1175. https://doi.org/10.1080/14656566.2025.2516617
  32. Fang Y, Wang X, Luo K, Dakal TC, Bai H, Xu C, Zhang G. Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications. Medicine Communications. 2026;7(5):e70732. https://doi.org/10.1002/mco2.70732
slide-cover
slide-cover
slide-cover
slide-cover

Рекомендуем статьи по данной теме:

Взаимосвязь параметров метаболизма опухоли по данным ПЭТ/КТ с аминокислотами с экспрессией EGFR.Вопросы нейрохирургии имени Н.Н. Бурденко. 2026;90(5):39-45

«Троянский конь» для глиобластомы: стратегия целевой доставки аптамеров.Вопросы нейрохирургии имени Н.Н. Бурденко. 2025;89(6-2):50-56

Издательство «Медиа Сфера»
РекламаДоставка/ОплатаО насКонтактыОбучение для редакцийПолитика конфиденциальностиПолитика обработки персональных данныхПубличная оферта на реализацию издательской продукции
ЖурналыПодпискаАрхивКнигиПроекты
  • RuStore

© 1998-2026

  • Телефоны издательства:

  • +7 (495) 482-41-18
  • +7 (495) 482-43-29

  • Прямой телефон отдела подписки
    (только по вопросам заказов и доставки журналов)

  • +7 (800) 250-18-12

  • пн-пт с 10:00 до 18:00

  • Telegram
  • VK
info@mediasphera.ru

  • Почтовый адрес:

  • Издательство «Медиа Сфера»,
    а/я 54, Москва, Россия, 127238

  • RuStore

© 1998-2026